News & Media

Press Releases

Back to News & Media

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)


RSS Feeds Email

Meaningful innovation at a glance.

Download our corporate fact sheet.

Download